0001104659-23-000143.txt : 20230103 0001104659-23-000143.hdr.sgml : 20230103 20230103094506 ACCESSION NUMBER: 0001104659-23-000143 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230103 DATE AS OF CHANGE: 20230103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cooper Joseph Patrick CENTRAL INDEX KEY: 0001368711 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37846 FILM NUMBER: 23500600 MAIL ADDRESS: STREET 1: PETER TSOFLIAS, C/O BLANK ROME LLP STREET 2: ONE LOGAN SQUARE, FL 9 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd. CENTRAL INDEX KEY: 0001671502 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 BUSINESS ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 BUSINESS PHONE: 97299741444 MAIL ADDRESS: STREET 1: 23 HATA'AS STREET CITY: KFAR SABA STATE: L3 ZIP: 44425 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biotechnology Ltd. DATE OF NAME CHANGE: 20160721 FORMER COMPANY: FORMER CONFORMED NAME: Cellect Biomed Ltd. DATE OF NAME CHANGE: 20160406 3 1 tm2233798-6_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-01-01 0 0001671502 Quoin Pharmaceuticals, Ltd. QNRX 0001368711 Cooper Joseph Patrick AZRIELI CENTER, ROUND TOWER, 30TH FLOOR 132 MENACHEM BEGIN BLVD TEL AVIV L3 6701101 ISRAEL 1 0 0 0 Share Option (right to buy) 0.0035 2023-04-12 2032-04-12 Ordinary Shares 64285600 D The option vests in four equal annual installments beginning on April 12, 2023. The number of securities underlying the option and the exercise price are listed in terms of ordinary shares, with five thousand (5,000) ordinary shares of the Issuer represented by one (1) American Depositary Share ("ADS"), which evidences the grant of an option to buy 12,857.12 ADSs at the exercise price of $17.50 per ADS. /s/ Joseph Cooper 2023-01-01